A 2011 animal study found BPC-157 reduced inflammatory markers in colitis models at rates comparable to standard anti-inflammatory treatments
Metformin in the digestive tract
Where you inject your GLP-1 agonist affects how quickly the drug reaches peak plasma levels, which in turn affects the timing of both therapeutic effects and side effects
Waldstein said that because GLP-1 is a natural body hormone, making claims about side effect management is not ultra-high risk
A prospective randomized, double-blind, placebo-controlled, doseresponse relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut micromicrobiota
Insights from Ozempic and Wegovy Users Insights from users of Ozempic and Wegovy, both formulations of semaglutide, have been featured prominently in discussions surrounding its effectiveness